Mycophenolic acid; an antibiotic from Penicillium brevicompactum Dlerckx

scientific article published on October 29, 2010

Mycophenolic acid; an antibiotic from Penicillium brevicompactum Dlerckx is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(46)90242-5
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0140673646902425?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0140673646902425?httpAccept=text/plain
P698PubMed publication ID21010114

P2093author name stringH. W. FLOREY
M. A. JENNINGS
P2860cites workBiochemical JournalQ864221
Studies in the biochemistry of micro-organisms: The molecular constitution of the metabolic products of Penicillium brevi-compactum Dierckx and related species. II. Mycophenolic acidQ38949144
Studies in the biochemistry of micro-organisms: The metabolic products of the Penicillium brevi-compactum seriesQ38949153
Studies in the biochemistry of micro-organisms: A note on the mechanism of the production of phenolic acids from glucose by Penicillium brevi-compactum DierckxQ39332037
A method for the assay of penicillinQ42577648
P433issue6385
P407language of work or nameEnglishQ1860
P921main subjectantibioticQ12187
PenicilliumQ843136
Penicillium brevicompactumQ7162860
Mycochromenic acidQ77567771
P304page(s)46-49
P577publication date1946-01-01
P1433published inThe LancetQ939416
P1476titleMycophenolic acid; an antibiotic from Penicillium brevicompactum Dlerckx
P478volume1

Reverse relations

cites work (P2860)
Q563359805-Hydroxymaltol and mycophenolic acid, secondary metabolites from Penicillium echinulatum
Q90080170Anti-Tumor Potential of IMP Dehydrogenase Inhibitors: A Century-Long Story
Q66935678Antitumor Agents II: Nitrogen Analogs of Mycophenolic Acid
Q27670715Bacillus anthracis Inosine 5′-Monophosphate Dehydrogenase in Action: The First Bacterial Series of Structures of Phosphate Ion-, Substrate-, and Product-Bound Complexes
Q34099261Bartolomeo Gosio, 1863-1944: an appreciation.
Q34086102Comparative tolerability of treatments for inflammatory bowel disease
Q69414524Determination of Mycophenolic Acid and Its Glucuronide Metabolite in Plasma
Q82147875Effect of pH of the medium on activity of streptomycin and penicillin and other chemotherapeutic substances
Q82092752Effect of some antibiotics on pathogenic fungi
Q38032010Enteric-coated mycophenolate sodium immunosuppression in renal transplant patients: efficacy and dosing.
Q92935023Environmental Risk Assessment for the Active Pharmaceutical Ingredient Mycophenolic Acid in European Surface Waters
Q32060938Immunosuppressive drugs in paediatric liver transplantation
Q71778184Mycophenolate mofetil
Q54034536Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
Q77844458Mycophenolate mofetil in pediatric renal transplantation
Q58979200Mycophenolic Acid: an Anti-cancer Compound with Unusual Properties
Q34611858Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability
Q66924804Mycophenolic acid in marketed cheeses
Q34999538New immunosuppressive drugs in dermatology (mycophenolate mofetil, tacrolimus): unapproved uses, dosages, or indications
Q42656145Physiological characterization of secondary metabolite producing Penicillium cell factories
Q41585655Preliminary risk-benefit assessment of mycophenolate mofetil in transplant rejection
Q104970544Some new metabolites related to mycophenolic acid
Q30356398The antibiotic potential of prokaryotic IMP dehydrogenase inhibitors
Q35574966The use of mycophenolate mofetil in liver transplant recipients
Q33957200The use of mycophenolate mofetil in transplant recipients
Q67340776Treatment Of Psoriasis With Oral Mycophenolic Acid

Search more.